MAIA Biotechnology, Inc.MAIANYSE

Revenue (LTM)

Net Income (LTM)

$-23M

-17.6% YoY

Free Cash Flow

$-16M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-7	-8↓11.6%	-16↓107.7%	-20↓24.8%	-17↑16.0%
Net Income	-7	-13↓88.4%	-16↓26.1%	-20↓25.4%	-23↓17.6%
EBITDA	0	-12	-16↓34.1%	-20↓25.4%	-23↓17.6%
EPS Diluted	-0.62	-1.18↓90.3%	-1.70↓44.1%	-1.49↑12.4%	-1.05↑29.5%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	1	11↑1493.8%	11↑3.6%	7↓34.7%	10↑34.3%
Total Current Assets	1	11↑1329.7%	12↑10.6%	8↓35.9%	10↑34.2%
Total Assets	1	11↑1417.4%	12↑6.1%	8↓37.1%	10↑34.2%
Total Current Liabilities	2	2↑26.7%	3↑52.3%	5↑51.0%	4↓22.4%
Total Liabilities	2	2↓9.2%	4↑63.8%	7↑101.7%	7↓8.0%
Total Equity	-3	9↑375.2%	9↓7.3%	0↓94.4%	4↑661.2%
Total Debt	0	0	0	0	0
Net Debt	-0	-11↓5195.0%	-11↓3.6%	-7↑34.7%	-10↓34.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-2	-4↓123.6%	-12↓193.4%	-13↓8.1%	-16↓20.1%
Capital Expenditure	0	0	0	0	0
Free Cash Flow	-2	-4↓123.6%	-12↓193.4%	-13↓8.1%	-16↓20.1%
Stock-Based Comp	4	3↓30.0%	2↓14.8%	3↑33.2%	2↓38.1%
Net Change in Cash	-1	10↑1047.4%	0↓96.2%	-4↓1109.0%	2↑164.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance